1. Home
  2. NBHC vs ZYME Comparison

NBHC vs ZYME Comparison

Compare NBHC & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Bank Holdings Corporation

NBHC

National Bank Holdings Corporation

HOLD

Current Price

$41.25

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$27.34

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBHC
ZYME
Founded
2009
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
2011
2022

Fundamental Metrics

Financial Performance
Metric
NBHC
ZYME
Price
$41.25
$27.34
Analyst Decision
Buy
Strong Buy
Analyst Count
3
11
Target Price
$47.67
$38.90
AVG Volume (30 Days)
298.8K
640.7K
Earning Date
04-21-2026
05-07-2026
Dividend Yield
3.03%
N/A
EPS Growth
N/A
33.33
EPS
1.04
N/A
Revenue
$47,100,000.00
$105,965,000.00
Revenue This Year
$39.96
$183.10
Revenue Next Year
$7.14
N/A
P/E Ratio
$40.16
N/A
Revenue Growth
2.86
38.87
52 Week Low
$35.06
$15.26
52 Week High
$47.28
$31.34

Technical Indicators

Market Signals
Indicator
NBHC
ZYME
Relative Strength Index (RSI) 39.49 50.65
Support Level $40.47 $22.26
Resistance Level $42.74 $29.75
Average True Range (ATR) 0.61 1.62
MACD 0.06 -0.15
Stochastic Oscillator 43.48 31.25

Price Performance

Historical Comparison
NBHC
ZYME

About NBHC National Bank Holdings Corporation

National Bank Holdings Corp offers a full range of banking products and financial services to commercial, business, and consumer clients predominantly in Colorado, with a focus on personalized service through relationship managers and banking center associates. The company provides commercial and industrial loans, non-owner occupied commercial real estate loans, Small Business Administration loans as a Preferred Lender Provider, U.S. Department of Agriculture and Farm Service Agency loans, commercial deposit and treasury management products, business online and mobile banking, consumer and residential real estate loans, deposit services, and trust and wealth management services. Its services emphasize full-relationship banking, integrating lending, deposits, and cash management solutions.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: